Approaches to the Formation of the Key 2-Oxabicyclo[3.3.0]-octan-3-one Precursor of Galiellalactone

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

New vicinal all-cis-trisubstituted derivatives of cyclopentane- and cyclopentene-containing triols were synthesized.

全文:

受限制的访问

作者简介

A. Gimazetdinov

Ufa Institute of Chemistry UFRS RAS

编辑信件的主要联系方式.
Email: gimazetdinov@anrb.ru
ORCID iD: 0000-0002-8539-3442
俄罗斯联邦, prosp. Oktyabrya, 71, Ufa, 450054

V. Zagitov

Ufa Institute of Chemistry UFRS RAS

Email: gimazetdinov@anrb.ru
俄罗斯联邦, prosp. Oktyabrya, 71, Ufa, 450054 Russia

Z. Makaev

Ufa Institute of Chemistry UFRS RAS

Email: gimazetdinov@anrb.ru
ORCID iD: 0000-0002-0958-3164
俄罗斯联邦, prosp. Oktyabrya, 71, Ufa, 450054

参考

  1. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Ред. Каприн А.Д. и др. М.: МНИОИ им. П.А. Герцена филиал ФГБУ “НМИЦ радиологии” Минздрава России. 2022, ISBN 978-5-85502-280-33
  2. Corrie P.G. Medicine. 2008, 36, 24–28. Debnath B., Xu S., Neamati N. J. Med. Chem. 2012, 55, 6645–6668. Yu H., Lee H., Herrmann A., Buettner R., Jove R. Nat. Rev. Cancer. 2014, 14, 736–746. https://www.nature.com/articles/nrc3818.
  3. Weidler M., Rether J., Anke T., Erkel G. FEBS Lett. 2000, 484, 1–6. doi: 10.1016/S0014-5793(00)02115-3
  4. Hautzel R., Anke H. Naturforsch. 1990, 45, 1093–1098. doi: 10.18632/oncotarget.6606
  5. Koepcke B., Johansson M., Sterner O., Anke H. (2002) J. Antibiot. 2002, 55, 36–40. doi: 10.7164/antibiotics.55.36
  6. Escobar Z., Williams H., Phipps R., Karunakaran D., Steele J., Sterner O. Phytochem. Lett. 2015, 12, 138–141. doi: 10.1016/j.phytol.2015.03.009
  7. Johansson M., Koepcke B., Anke H., Sterner O. J. Antibiot. 2002, 55, 104–106. doi: 10.7164/antibiotics.55.104
  8. Nussbaum F.V., Hanke R., Fahrig T., Benet-Buchholz J. Eur. J. Org. Chem. 2004, 13, 2783–2790. doi: 10.1002/ejoc.200400137
  9. Johansson M., Sterner O. Org. Lett. 2001, 3, 2843–2845. doi: 10.1021/ol016286+
  10. Canesin G., Maggio V., Palominos M., Stiehm A., Contreras H.R., Castellón E.A., Morote J., Paciucci R., Maitland N.J., Bjartell A., Hellsten R. Sci. Rep. 2020, 10, 1–12. doi: 10.1038/s41598-020-70948-5
  11. Hellsten R., Johansson M., Dahlman A., Sterner O., Bjartell A. PLoS ONE. 2011, 6, e22118. doi: 10.1371/journal.pone.0022118
  12. Rudolph K., Serwe A., Erkel G. Cytokine. 2013, 61, 285–296. doi: 10.1016/j.cyto.2012.10.011
  13. Zhang Q., Feng Y., Kennedy D. Cell. Mol. Life Sci. 2017, 74, 777–801. doi: 10.1007/s00018-016-2362-3
  14. Hausding M., Tepe M., Übel C., Lehr H.A., Röhrig B., Höhn Y., Pautz A., Eigenbrod T., Anke T., Kleinert H., Erkel G., Finotto S. Int. Immunol. 2011, 23, 1–15. doi: 10.1093/intimm/dxq451
  15. Bollmann F., Jäckel S., Schmidtke L., Schrick K., Reinhardt C., Jurk K., Wu Z., Xia N., Li H., Erkel G., Walter U., Kleinert H., Pautz A. PLoS ONE. 2015, 10, e0130401. -doi: 10.1371/journal.pone.0130401
  16. Pérez M., Soler-Torronteras R., Collado J.A., Limones C.G., Hellsten R., Johansson M., Sterner O., Bjar-tell A., Calzado M.A., Muñoz E. Chem. Biol. Interact. 2014, 214, 69–76. doi: 10.1016/j.cbi.2014.02.012
  17. Weidler M., Rether J., Anke T., Erkel G. FEBS Lett. 2014, 484, 1–6. doi: 10.1016/S0014-5793(00)02115-3
  18. Busker S., Page B., Arnér E.S. Redox. Biol. 2020, 36, 101646. doi: 10.1016/j.redox.2020.101646
  19. Garrido-Rodríguez M., Ortea I., Calzado M.A., Muñoz E., García V. J. Proteomics. 2019, 193, 217–229. doi: 10.1016/j.jprot.2018.10.012
  20. Hellsten R., Johansson M., Dahlman A., Dizeyi N., Sterner O., Bjartell A. Prostate. 2008, 68, 269–280. doi: 10.1002/pros.20699
  21. Johansson M., Köpcke B., Anke H., Sterner O. Angew. Chem. Int. Ed. 2002, 41, 2158–2160. doi: 10.1002/1521-3773(20020617)41:12%3c2158::AID-ANIE2158%3e3.0.CO;2-P
  22. Johansson M., Köpcke B., Anke H., Sterner O. Tetrahedron. 2002, 58, 2523–2528. doi: 10.1016/S0040-4020(02)00134-5
  23. Kim T., Han Y.T., An H., Kim K., Lee J., Suh Y.G. J. Org. Chem. 2015, 80, 12193–12200. doi: 10.1021/acs.joc.5b02121
  24. Lu Y., Zhao S., Zhou S., Chen S.C., Luo T. Org. Biomol. Chem. 2019, 17, 1886–1892. doi: 10.1039/C8OB01915K
  25. Gidlöf R., Johansson M., Sterner O. Org. Lett. 2010, 12, 5100–5103. doi: 10.1021/ol101989m
  26. Kim H.S., Kim T., Ko H., Lee J., Kim Y.S., Suh Y.G. Bioorg. Med. Chem. 2017, 25, 5032–5040. doi: 10.1016/j.bmc.2017.06.036
  27. Johansson M., Sterner O. Ам. заявка US 10781197B2, 2020-09-22. https://patents.google.com/patent/US10781197B2/en
  28. Gimazetdinov A.M., Gimazetdinova T.V., Miftakhov M.S. Mendeleev Commun. 2010, 20, 15–16. doi: 10.1016/j.mencom.2010.01.006
  29. Gimazetdinov A.M., Gataullin S.S., Bushmarinov I.S., Miftakhov M.S. Tetrahedron. 2012, 68, 5754–5758. doi: 10.1016/j.tet.2012.05.036
  30. Gimazetdinov A.M., Al’mukhametov A.Z., Miftakhov M.S. New J. Chem. 2022, 46, 6708–6714. doi: 10.1039/d2nj01003h
  31. Gimazetdinov A.M., Al’mukhametov A.Z., Loza V.V., Spirikhin L.V., Miftakhov M.S. Mendeleev Commun. 2018, 28, 546–547. doi: 10.1016/j.mencom.2018.09.033

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. Galiellalactones, their precursors and promising analogues.

下载 (152KB)
索引源数据
3. Scheme 1

下载 (110KB)
索引源数据
4. Scheme 2

下载 (86KB)
索引源数据
5. Scheme 3

下载 (171KB)
索引源数据
6. Scheme 4

下载 (257KB)
索引源数据
7. Approaches to the formation of the key 2-oxabicyclo[3.3.0]octane-3-one precursor of galiellalactone

下载 (47KB)
索引源数据

版权所有 © Russian Academy of Sciences, 2024